GSK Market Cap

GSK has a market cap or net worth of $73.48 billion as of May 16, 2025. Its market cap has decreased by -12.92% in one year.

Market Cap

73.48B

Enterprise Value

91.34B

1-Year Change

-12.92%

Ranking

#193

Market Cap Chart

Since December 1, 1998, GSK's market cap has decreased from $159.34B to $73.48B, a decrease of -53.88%. That is a compound annual growth rate of -2.88%.

Market Cap History

Date	Market Cap	% Change
May 14, 2025	74.03B	7.97%
Dec 31, 2024	68.57B	-8.74%
Dec 29, 2023	75.14B	6.12%
Dec 30, 2022	70.81B	-35.88%
Dec 31, 2021	110.43B	20.28%
Dec 31, 2020	91.81B	-21.29%
Dec 31, 2019	116.64B	23.14%
Dec 31, 2018	94.72B	8.77%
Dec 29, 2017	87.08B	-7.13%
Dec 30, 2016	93.77B	-4.44%
Dec 31, 2015	98.13B	-5.42%
Dec 31, 2014	103.75B	-21.06%
Dec 31, 2013	131.43B	19.76%
Dec 31, 2012	109.74B	-7.43%
Dec 30, 2011	118.55B	16.46%
Dec 31, 2010	101.79B	-7.10%
Dec 31, 2009	109.58B	17.51%
Dec 31, 2008	93.25B	-31.55%
Dec 31, 2007	136.24B	-6.62%
Dec 29, 2006	145.90B	52.77%
Dec 31, 2002	95.50B	-24.81%
Dec 31, 2001	127.01B	-11.04%
Dec 29, 2000	142.77B	0.22%
Dec 31, 1999	142.45B	-19.60%
Dec 31, 1998	177.18B	11.20%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	642.38B
Johnson & Johnson	352.15B
AbbVie	313.43B
Novo Nordisk	288.64B
UnitedHealth Group	279.41B
Abbott Laboratories	223.67B
Novartis AG	208.47B
AstraZeneca	206.71B

Market Cap Rankings